Join to access to all OVN content. Join for Free
Positive Mindset = Positive Outcomes
Positive mindset overcoming negativity bias mindfulness techniques mindset-driven recovery positive habits

Positive Mindset = Positive Outcomes


Share This Article


Summary

In this episode, Don Sandel from Go Positive joins Tom Caravela to explore the power of a positive mindset. They delve into the science behind positivity, introducing the DOSE acronym and discussing the effects of overcoming negativity bias. Don shares techniques for fostering positivity through relationships, self-talk, and mindfulness. The conversation includes practical tips on meditation, choosing happiness, and using technology and exercise to build positive habits. They emphasize the importance of accountability and a supportive social environment. The episode wraps up with inspiring stories of mindset-driven recovery and a note of gratitude.

This weeks MSL Talk podcast guest is Don Sandel, the Founder, speaker, and facilitator at GoPositiv and best-selling author and performance coach who shares research-based solutions for adopting a positive mindset which leads to positive outcomes.

Don shares…

👉 What led him to write his book “Positive Mindshift”
👉 What is most important for people when it comes to mindset
👉 How people can break the habit of negativity bias
👉 What ways we can shift our thoughts and retrain our brain
👉 What kind of daily habits and mindset techniques we can adopt each day

Click for Source
Positive mindset, overcoming negativity bias, mindfulness techniques, mindset-driven recovery, positive habits

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Things will be HARD…but YOU can do hard things!
Partner Avatar MSL Talk: Tom Caravela

Things will be HARD…but YOU can do hard things!

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Explore OVN